Clinical Trials List
2015-09-15 - 2019-09-30
Phase III
Terminated11
ICD-10C15
Malignant neoplasm of esophagus
-
Trial Applicant
Linical
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- TA-CHEN HUANG Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Chang-Fang Chiu Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Chun-Lung Feng Digestive System Department
- 方信元 Division of Thoracic Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chueh-Chuan Yen Division of Hematology & Oncology
- 黃建勝 Division of Thoracic Surgery
- Yu-Chung Wu Division of Thoracic Surgery
- Yi-Ping Hung Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- 陳盛裕 未分科
- Muh-Hwa Yang Division of Hematology & Oncology
- Sheng-Yu Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
10 Terminated
Audit
None
Co-Principal Investigator
- 賴冠銘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 姜乃榕 Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Nai-Jung Chiang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- 黃泰霖 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 呂宏益 Division of General Surgery
- Yu-Li Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Li-Tzong Chen Digestive System Department
- Yi-Chang Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 高明蔚 Division of Thoracic Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
Audit
CRO
Co-Principal Investigator
- Ming-Mo Hou Division of Hematology & Oncology
- 陳煥武 Division of Radiology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- Chi-Ju Yeh Division of Others -
- Mengting Peng Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
Audit
CRO
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
72 participants
-
Global
390 participants
